Año: 2016
Journal Impact Factor (JIF): 6.6880
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | 12/160 | Q1 | T1 | D1 |
GENETICS & HEREDITY | SCIE | 14/167 | Q1 | T1 | D1 |
MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 9/128 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 2,320
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 9/162 | Q1 | T1 | D1 | 94,75 |
GENETICS & HEREDITY | 10/179 | Q1 | T1 | D1 | 94,69 |
MEDICINE, RESEARCH & EXPERIMENTAL | 8/185 | Q1 | T1 | D1 | 95,95 |
Año:
2016
CiteScore:
13,500
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Drug Discovery | 5/143 | Q1 | T1 | D1 |
Genetics | 16/306 | Q1 | T1 | D1 |
Molecular Biology | 25/358 | Q1 | T1 | D1 |
Molecular Medicine | 8/157 | Q1 | T1 | D1 |
Pharmacology | 7/304 | Q1 | T1 | D1 |
SJR año:
2016
Factor de Impacto:
3,362
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Drug Discovery | 3/180 | Q1 | T1 | D1 |
Genetics | 29/351 | Q1 | T1 | D1 |
Medicine (miscellaneous) | 64/2809 | Q1 | T1 | D1 |
Molecular Medicine | 8/180 | Q1 | T1 | D1 |
Pharmacology | 8/340 | Q1 | T1 | D1 |
Molecular Biology | 45/417 | Q1 | T1 | D2 |
Agencia | Código de Proyecto |
---|---|
CICE | - |
CS de la Junta de Andalucia FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia | P09-CTS-04532; PI-57069; PI-0001/2009; PAIDI-Bio-326; PI-0160/2012; PI-0407/2012; SAS-111244; P10-CTS/6406 |
Fondo de Investigaciones Sanitarias ISCIII (Spain) | - |
Fondo Europeo de Desarrollo Regional (FEDER) from the European Union | PI12/01598; PI12/01097; CD09/00200; CP09/00228; PI12/01390; CP12/03175; CP09/0063 |
ISCIII Red de Terapia Celular | RD12/0019/0006 |
# | Autor | Afiliación |
---|---|---|
1 | Toscano, MG | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research; Amarna Therapeut SL (Spain) |
2 | Muñoz, P | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research; University College London Institute of Child Health (Spain) |
3 | Sánchez-Gilabert, A | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
4 | Cobo, M | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
5 | Benabdellah, K | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
6 | Anderson, P | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
7 | Ramos-Mejía, V | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
8 | Real, PJ | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |
9 | Neth, O | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS) (Spain) |
10 | Molinos-Quintana, A | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS) (Spain) |
11 | Gregory, PD | Sangamo Therapeutics, Inc. (USA) |
12 | Holmes, MC | Sangamo Therapeutics, Inc. (USA) |
13 | Center Pfizer-University of Granada-Andalusian Board of Genomics and Oncology Research (Spain) |